Eris Lifesciences to buy additional stake in Kinedex
Eris Lifesciences on Saturday said it will buy additional 17.81 per cent share in its step-down firm Kinedex, making it wholly-owned subsidiary.
Eris Lifesciences has entered into a share purchase agreement with Rajesh Dhuria, one of the founders and promoters of Kinedex with the intent to have full ownership and control of the said subsidiary, it said. Image source: Pixabay